R3 Vascular

Mountain View, United States

R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.

$87.0M raised

May 2024

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has R3 Vascular raised?

R3 Vascular has raised $87.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.

Who are R3 Vascular's investors?

R3 Vascular's investors include Deerfield Management, 415 Capital.

Where is R3 Vascular headquartered?

R3 Vascular is headquartered in Mountain View, United States.

What does R3 Vascular do?

R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.

What stage is R3 Vascular at?

R3 Vascular is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 9, 2024.

MLA

"R3 Vascular — Funding & Investors." VCBacked, May 9, 2024, https://www.vcbacked.co/company/r3-vascular. Accessed July 2, 2026.

APA

VCBacked. (2024). R3 Vascular — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/r3-vascular

Wikipedia (cite web)

{{cite web |title=R3 Vascular — Funding & Investors |url=https://www.vcbacked.co/company/r3-vascular |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 9, 2024.